Intellia Therapeutics Inc buy William Blair
Start price
25.03.23
/
50%
€35.09
Target price
25.03.24
-
Performance (%)
-29.81%
End price
26.03.24
€24.63
Summary
This prediction ended on 26.03.24 with a price of €24.63. The price of Intellia Therapeutics Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -29.81%. William_Blair has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. William_Blair has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intellia Therapeutics Inc | 4.102% | 4.102% | 21.717% | -69.173% |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% | 64.061% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% | 86.918% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% | 77.872% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% | 68.192% |
Comments by William_Blair for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von William_Blair gewählte maximale Laufzeit wurde überschritten
Current prediction by William_Blair for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€12.98
02.03.26
02.03.26
-
02.03.27
02.03.27
-17.87%
20.08.26
20.08.26
